Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Self-Management Using Smartphone Application for Chronic Disease Care in Real siTuation (SMART-Asthma): Adult

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01918293
Recruitment Status : Completed
First Posted : August 7, 2013
Last Update Posted : November 27, 2013
Sponsor:
Information provided by (Responsible Party):
Jongha Park, Inje University

Brief Summary:
Bronchial asthma is an chronic airway disease with bronchial hypersensitivity due to inflammation and bronchial muscle contraction. It can cause recurrent dyspnea, cough, wheezing and severe life-threatening attack and lower quality of life. In addition, it make large amount of socioeconomic loss as about 3.7 billion US dollars.

Condition or disease Intervention/treatment Phase
BRONCHIAL ASTHMA Device: SMART ARM Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Self-Management Using Smartphone Application for Chronic Disease Care in Real siTuation (SMART-Asthma) in Adult
Study Start Date : September 2012
Actual Primary Completion Date : September 2013
Actual Study Completion Date : October 2013

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: SMART arm
Using smartphone application for control of asthma
Device: SMART ARM
The smartphone application for self-management of Asthma offers symptom diary, general information for asthma, the information of asthma drugs,the guideline for inhaler and the specific action plan according to daily symptom and FEV1.
Other Name: SMART-Asthma

No Intervention: conventional arm
non-using smartphone application for control asthma



Primary Outcome Measures :
  1. The efficacy of smartphone application for asthma control test (ACT)and quality of life [ Time Frame: at least 2 times a week ]
    Using ACT and ALQL score (QoL), we will investigate the efficacy of smanrtphone application for control of asthma compared to smartphone app. using group and smartphone app. non-using group


Secondary Outcome Measures :
  1. FEV1 (Forced expiratory volume in 1 second ) and FVC (Forced vital capacity) [ Time Frame: at least 1 time a month ]
    Using spirometer to check the variation of FEV1,we will investigate the efficacy of smanrtphone application for control of asthma compared to smartphone app. using group and smartphone app. non-using group

  2. Acute exacerbation of bronchial asthma [ Time Frame: at least 1 time a week ]
    Using medical record and questionaire of acute exacerbation,we will investigate the efficacy of smanrtphone application for control of asthma compared to smartphone app. using group and smartphone app. non-using group



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • using smartphone
  • alleged bronchial asthma over 3months & positive of bronchodilator response test or bronchial provocation test

Exclusion Criteria:

  • COPD
  • active pulmonary TUBERCULOSIS
  • Acute exacerbation within 4weeks
  • severe psychological disorder
  • severe systemic disease; severe LC, ESRD ...
  • MALIGNANCY

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01918293


Locations
Layout table for location information
Korea, Republic of
Haeundae Paik Hospital
Busan, Korea, Republic of, 612-896
Sponsors and Collaborators
Inje University

Layout table for additonal information
Responsible Party: Jongha Park, Study principal investigator, Inje University
ClinicalTrials.gov Identifier: NCT01918293     History of Changes
Other Study ID Numbers: SMART-ASTHMA (ADULT)
First Posted: August 7, 2013    Key Record Dates
Last Update Posted: November 27, 2013
Last Verified: November 2013

Keywords provided by Jongha Park, Inje University:
ASTHMA
SMARTPHONE APPLICATION

Additional relevant MeSH terms:
Layout table for MeSH terms
Asthma
Chronic Disease
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases
Disease Attributes
Pathologic Processes